Hot Penny Stocks

Cannabis Penny Stocks

US-listed cannabis and marijuana penny stocks, priced $0.50 to $5, ranked by today's percentage change. Cultivators, MSOs (multi-state operators), edibles, REITs with cannabis tenants, and ancillary plays — everything tagged to the cannabis theme. Updated intraday.

Data as of 8/29/2026 6:08:02 AM · Intraday prices · 18 penny stocks in theme

#	Symbol	Company	Sector	Price	Day Chg	Volume
1	AFCG	Advanced Flower Capital Inc. Common Stock	Financials	$3.4730	+3.78%	99K
2	VFF	Village Farms International, Inc. Common Shares	Consumer Staples	$2.9050	+1.05%	661K
3	SNDL	Sundial Growers Inc. Common Shares	Consumer Discretionary	$1.3550	+0.74%	353K
4	GNLN	Greenlane Holdings, Inc. Class A Common Stock	Consumer Discretionary	$2.7550	+0.72%	2K
5	TLRY	Tilray Brands, Inc. Common Stock	Healthcare	$4.5850	+0.22%	3.2M
6	ARTL	Artelo Biosciences, Inc. Common Stock	Healthcare	$0.7200	+0.14%	157K
7	CGC	Canopy Growth Corporation Common Shares	Healthcare	$0.9850	0.00%	891K
8	XXII	22nd Century Group Inc.	Consumer Staples	$3.2150	0.00%	13K
9	MIRA	MIRA Pharmaceuticals, Inc. Common Stock	Healthcare	$0.7490	0.00%	5K
10	ISPR	Ispire Technology Inc. Common Stock	Consumer Staples	$1.4050	0.00%	1K
11	ACB	Aurora Cannabis Inc. Common Shares	Healthcare	$3.9840	-0.25%	1.1M
12	INM	InMed Pharmaceuticals Inc. Common Shares	Healthcare	$1.4050	-0.35%	111K
13	CRON	Cronos Group Inc. Common Share	Healthcare	$3.3650	-0.44%	423K
14	OGI	Organigram Global Inc. Common Shares	Healthcare	$1.1950	-0.81%	204K
15	GRWG	GROW GENERATION CORP	Consumer Discretionary	$1.6250	-1.81%	246K
16	HITI	High Tide Inc. Common Shares	Consumer Discretionary	$2.5440	-2.14%	138K
17	AKAN	Akanda Corp. Common Shares	Healthcare	$3.9900	-3.78%	89K
18	IMCC	IM Cannabis Corp. Common Shares	Healthcare	$3.5830	-11.68%	73K

What Drives Cannabis Penny Stocks

Cannabis at the sub-$5 level is a uniquely policy-driven trade. Federal cannabis is still Schedule I in the US (as of mid-2026), but rescheduling discussions, state legalization progress, banking access (SAFE Banking Act), and DOJ enforcement signals all move the entire group simultaneously. A single news headline can lift or sink the whole sub-$5 cannabis universe in a session.

Catalysts to know: DEA rescheduling decisions, SAFE Banking Act movement, state ballot initiatives, 280E tax interpretations, FDA cannabidiol rulings.
Banking constraint: federal status means most cannabis companies still cannot use traditional banking. This shows up as cash inefficiency, expensive financing, and recurring dilution.
OTC dominance: many cannabis names are on OTC Pink or OTCQX rather than major exchanges — see OTC vs Nasdaq for the disclosure differences.
State patchwork: companies with footprints in mature legal states (CA, CO, MA, IL) trade differently than those focused on newly-legal states; revenue ramps are stop-start.
Brand vs. wholesale: branded edibles/flower plays earn premium multiples; wholesale cultivators trade like commodities.
M&A consolidation: larger MSOs periodically scoop up sub-$5 names; takeout premiums of 30-100% have happened repeatedly.